A detailed history of Simplex Trading, LLC transactions in Novavax Inc stock. As of the latest transaction made, Simplex Trading, LLC holds 267,431 shares of NVAX stock, worth $3.11 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
267,431
Holding current value
$3.11 Million
% of portfolio
0.11%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$3.89 - $20.97 $1.04 Million - $5.61 Million
267,431 New
267,431 $3.39 Million
Q2 2023

Aug 04, 2023

BUY
$6.67 - $9.52 $667 - $952
100 Added 100.0%
200 $1,000
Q1 2023

Apr 27, 2023

SELL
$5.76 - $12.48 $3,715 - $8,049
-645 Reduced 86.58%
100 $0
Q3 2022

Nov 04, 2022

SELL
$18.2 - $76.12 $1.34 Million - $5.6 Million
-73,584 Reduced 99.0%
745 $13,000
Q2 2022

Aug 03, 2022

SELL
$36.28 - $75.29 $397,229 - $824,350
-10,949 Reduced 12.84%
74,329 $3.82 Million
Q1 2022

May 02, 2022

SELL
$69.73 - $142.9 $2.49 Million - $5.09 Million
-35,639 Reduced 29.47%
85,278 $6.28 Million
Q4 2021

Feb 23, 2022

BUY
$134.56 - $217.97 $7.53 Million - $12.2 Million
55,977 Added 86.2%
120,917 $17.3 Million
Q3 2021

Oct 28, 2021

SELL
$177.8 - $270.58 $164,820 - $250,827
-927 Reduced 1.41%
64,940 $14 Million
Q2 2021

Aug 12, 2021

BUY
$121.0 - $257.67 $4.6 Million - $9.8 Million
38,016 Added 136.5%
65,867 $14 Million
Q1 2021

Apr 26, 2021

SELL
$112.98 - $319.93 $1.18 Million - $3.34 Million
-10,451 Reduced 27.29%
27,851 $5.05 Million
Q4 2020

Feb 02, 2021

BUY
$78.74 - $139.5 $637,951 - $1.13 Million
8,102 Added 26.83%
38,302 $4.27 Million
Q3 2020

Oct 14, 2020

BUY
$79.44 - $178.51 $2.4 Million - $5.39 Million
30,200 New
30,200 $3.27 Million
Q2 2020

Jul 13, 2020

SELL
$13.86 - $83.61 $63,894 - $385,442
-4,610 Closed
0 $0
Q1 2020

Apr 29, 2020

BUY
$3.93 - $16.0 $18,117 - $73,760
4,610 New
4,610 $62,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $910M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.